Catalyst Pharmaceuticals Acquired by Angelini Pharma | Healthcare M&A Deal

Angelini Pharma has acquired Catalyst Pharmaceuticals, a pharmacy business in Florida, for $31.50. Catalyst Pharmaceuticals is a healthcare company focused on pharmacy-related products and services, with operations tied to Coral Gables, Florida. Angelini Pharma acquisitions in healthcare M&A aim to expand strategic capabilities through a merger acquisition of Catalyst Pharmaceuticals. The announced merger acquisition is structured as an agreement and plan of merger between Angelini Pharma and a Delaware Merger Sub, with stockholder votes scheduled for a virtual special meeting on July 8, 2026.